Amphastar Pharmaceuticals (AMPH) Current Ratio: History & Chart

Amphastar Pharmaceuticals, Inc.(AMPH)

Drug Manufacturers - Specialty & Generic · Rancho Cucamonga, CA

$25.67+0.30 (+1.20%)

Delayed quote: Oct 6, 2026, 12:00 PM EDT

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.

Rancho Cucamonga, CA

1,976 employees

www.amphastar.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Yongfeng Zhang

View full financials

AMPH Current Ratio Metrics

CURRENT RATIO

2.40

CURRENT RATIO AVG TTM

3.34

CURRENT RATIO AVG 3Y

2.90

CURRENT RATIO AVG 5Y

3.08

CURRENT RATIO AVG 10Y

2.88

CURRENT RATIO AVG 15Y

N/A

CURRENT RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-28.14%

CURRENT VS 3Y AVG

-17.22%

CURRENT VS 5Y AVG

-22.24%

CURRENT VS 10Y AVG

-16.68%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.52

median of 723 covered companies

CURRENT VS SECTOR MEDIAN

-31.90%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Amphastar Pharmaceuticals, Inc. (AMPH)	$1.13B	2.40	3.34	2.90	3.08
Harrow Health, Inc. (HROW)vs ›	$1.14B	2.24	2.14	3.36	3.91
OPKO Health, Inc. (OPK)vs ›	$1.14B	3.35	3.70	2.70	2.45
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.15B	33.10	10.19	10.19	10.19
Replimune Group, Inc. (REPL)vs ›	$1.11B	5.23	6.37	10.25	15.62
GoodRx Holdings, Inc. (GDRX)vs ›	$1.15B	1.38	3.96	6.78	9.79
Nektar Therapeutics (NKTR)vs ›	$1.16B	10.42	4.62	5.92	7.14
Damora Therapeutics, Inc. (DMRA)vs ›	$1.17B	19.73	13.53	9.78	15.63
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.10B	11.59	21.25	14.51	14.51
IRadimed Corporation (IRMD)vs ›	$1.09B	9.46	8.41	7.63	9.11

NAME

MARKET CAP

CURRENT RATIO

TTM

Amphastar Pharmaceuticals, Inc. (AMPH)

$1.13B

2.40

3.34

2.90

3.08

Harrow Health, Inc. (HROW)vs ›

$1.14B

2.24

2.14

3.36

3.91

OPKO Health, Inc. (OPK)vs ›

$1.14B

3.35

3.70

2.70

2.45

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.15B

33.10

10.19

Replimune Group, Inc. (REPL)vs ›

$1.11B

5.23

6.37

10.25

15.62

GoodRx Holdings, Inc. (GDRX)vs ›

$1.15B

1.38

3.96

6.78

9.79

Nektar Therapeutics (NKTR)vs ›

$1.16B

10.42

4.62

5.92

7.14

Damora Therapeutics, Inc. (DMRA)vs ›

$1.17B

19.73

13.53

9.78

15.63

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.10B

11.59

21.25

14.51

IRadimed Corporation (IRMD)vs ›

$1.09B

9.46

8.41

7.63

9.11

Current Ratio FAQ

What is the current ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The current ratio for AMPH stock is 2.40.

Is Amphastar Pharmaceuticals, Inc.'s current ratio high or low?

The current ratio of 2.40 is 22% below its 5-year average of 3.08, around the middle of its 5-year range (1.53–4.02).

What is the TTM average current ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The TTM average current ratio for AMPH stock is 3.34.

What is the 3Y average current ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 3Y average current ratio for AMPH stock is 2.90.

What is the 5Y average current ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 5Y average current ratio for AMPH stock is 3.08.

What is the 10Y average current ratio for Amphastar Pharmaceuticals, Inc. (AMPH)?

The 10Y average current ratio for AMPH stock is 2.88.

DATE	CURRENT RATIO
2026-06-30	2.40
2026-03-31	3.85
2025-12-31	4.02
2025-09-30	3.12
2025-06-30	3.29
2025-03-31	2.95
2024-12-31	3.07
2024-09-30	3.43
2024-06-30	3.52
2024-03-31	2.18
2023-12-31	2.17
2023-09-30	2.10
2023-06-30	1.53
2023-03-31	3.86
2022-12-31	3.99
2022-09-30	3.76
2022-06-30	3.64
2022-03-31	3.19
2021-12-31	3.06
2021-09-30	3.10
2021-06-30	2.50
2021-03-31	2.36
2020-12-31	2.49
2020-09-30	2.86
2020-06-30	2.86
2020-03-31	2.96
2019-12-31	2.84
2019-09-30	3.11
2019-06-30	2.81
2019-03-31	2.06
2018-12-31	2.06
2018-09-30	2.02
2018-06-30	1.94
2018-03-31	2.40
2017-12-31	2.79
2017-09-30	3.07
2017-06-30	3.04
2017-03-31	2.63
2016-12-31	3.04
2016-09-30	3.13
2016-06-30	2.76
2016-03-31	2.67
2015-12-31	2.93
2015-09-30	2.82
2015-06-30	2.94
2015-03-31	2.81
2014-12-31	3.16
2014-09-30	3.41
2014-06-30	3.81
2014-03-31	2.43
2013-12-31	2.64
2013-09-30	2.38
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	2.76

DATE

CURRENT RATIO

2026-06-30

2.40

2026-03-31

3.85

2025-12-31

4.02

2025-09-30

3.12

2025-06-30

3.29

2025-03-31

2.95

2024-12-31

3.07

2024-09-30

3.43

2024-06-30

3.52

2024-03-31

2.18

2023-12-31

2.17

2023-09-30

2.10

2023-06-30

1.53

2023-03-31

3.86

2022-12-31

3.99

2022-09-30

3.76

2022-06-30

3.64

2022-03-31

3.19

2021-12-31

3.06

2021-09-30

3.10

2021-06-30

2.50

2021-03-31

2.36

2020-12-31

2.49

2020-09-30

2.86

2020-06-30

2.86

2020-03-31

2.96

2019-12-31

2.84

2019-09-30

3.11

2019-06-30

2.81

2019-03-31

2.06

2018-12-31

2.06

2018-09-30

2.02

2018-06-30

1.94

2018-03-31

2.40

2017-12-31

2.79

2017-09-30

3.07

2017-06-30

3.04

2017-03-31

2.63

2016-12-31

3.04

2016-09-30

3.13

2016-06-30

2.76

2016-03-31

2.67

2015-12-31

2.93

2015-09-30

2.82

2015-06-30

2.94

2015-03-31

2.81

2014-12-31

3.16

2014-09-30

3.41

2014-06-30

3.81

2014-03-31

2.43

2013-12-31

2.64

2013-09-30

2.38

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

2.76

Current Ratio: 2.40

AMPH Current Ratio

AMPH Average Current Ratio Chart

AMPH Current vs Average Current Ratio Chart

AMPH Current Ratio Metrics

AMPH Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

AMPH Current Ratio History

Related Metrics